Cannara Biotech Inc. (LOVE : TSX)
Common Stock
$1.89
CAD
-0.03 (-1.56%)
Last updated: 2026-07-20
LOVE
Cannara Biotech Inc.
WealthAwesomePerformance
1 Day
-1.56%
1 Week
+5.59%
1 Month
+14.55%
YTD
+2.72%
Key Statistics
Market Cap
$189.66M
52W High
$2.05
52W Low
$1.55
P/E Ratio
17.45
50 Day MA
$1.72
200 Day MA
$1.77
Beta
0.35
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/20/2026 | $1.92 | $1.92 | $1.76 | $1.89 | $1.89 | 79,390 |
| 7/17/2026 | $1.93 | $1.94 | $1.90 | $1.92 | $1.92 | 21,904 |
| 7/16/2026 | $1.90 | $1.98 | $1.90 | $1.92 | $1.92 | 148,014 |
| 7/15/2026 | $1.90 | $1.92 | $1.85 | $1.88 | $1.88 | 79,990 |
| 7/14/2026 | $1.80 | $1.90 | $1.80 | $1.90 | $1.90 | 74,900 |
| 7/13/2026 | $1.81 | $1.81 | $1.79 | $1.79 | $1.79 | 25,610 |
| 7/10/2026 | $1.87 | $1.87 | $1.78 | $1.82 | $1.82 | 23,725 |
| 7/9/2026 | $1.84 | $1.87 | $1.82 | $1.87 | $1.87 | 16,851 |
| 7/8/2026 | $1.80 | $1.84 | $1.80 | $1.84 | $1.84 | 34,749 |
| 7/7/2026 | $1.85 | $1.85 | $1.80 | $1.80 | $1.80 | 8,519 |
Analyst Price Targets
Based on analyst covering LOVE
Wall Street analysts forecast LOVE stock price to rise 78.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
+78.6% Upside
Current Price
C$1.89
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
40.2%
Annualized
90-Day Vol
35.2%
Annualized
Trend (90d)
+11.3%
Annualized drift
90d Mean
C$1.97
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.92 | C$1.67 – C$2.20 |
| 60 trading days | C$1.94 | C$1.60 – C$2.36 |
| 90 trading days | C$1.97 | C$1.55 – C$2.50 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cannara Biotech Inc.
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Financials
- Revenue (TTM)
- $117.40M
- EBITDA
- $24.80M
- Profit Margin
- 9.25%
- ROE (TTM)
- 9.68%
- EPS (Diluted)
- 0.11
- Book Value
- 1.22
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About LOVE
Articles Featuring LOVE.TO
Latest articles and analysis covering LOVE.TO
Why Cannara Biotech Inc. stock is sliding today
Cannara Biotech Inc. is experiencing a notable decline in its stock price today, raising questions about investor confidence despite recent operational successes.
Why Cannara Biotech Inc. stock is rising today
Cannara Biotech Inc. (LOVE.TO) experienced a 2.66% increase in its stock price today, closing at CA$1.93. This rise is indicative of growing investor confidence as the company enhances its accessibility to U.S. markets.
What's Going On With Cannara Biotech Inc. Stock Wednesday?
Cannara Biotech Inc. (LOVE.TO) has seen a significant increase in its stock price this week, buoyed by positive performance metrics and strategic developments, despite no major news this week. The stock closed at C$1.88, reflecting a 6.15% increase on Wednesday.
Cannara Biotech Inc. LOVE Earnings Beat Estimates by 29.7%
Cannara Biotech Inc. (LOVE.TO) reported an EPS of 0.0389, beating estimates by 29.67%. This earnings surprise reflects the company's ongoing efforts to strengthen its market position and operational performance in the cannabis sector.
Why Cannara Biotech Inc. stock is skyrocketing today
Cannara Biotech Inc. has seen a significant uptick in its stock price today, closing at CA$1.90, driven by positive investor sentiment and strategic business developments.
Will Cannara Biotech Inc. (LOVE) Beat Earnings Estimates in Its Next Report?
As Cannara Biotech Inc. approaches its earnings report, the company is under scrutiny for its ability to meet a modest EPS estimate of $0.03. With a history of misses, investors are wondering if recent strategic initiatives will be enough to turn the tide.
Why Cannara Biotech Inc. stock is sliding today
Cannara Biotech Inc. (LOVE.TO) saw its stock price dip by 2.67% in the last trading session, closing at CA$1.82. This decline raises concerns about the company's market position and future performance.
Why Cannara Biotech Inc. stock is sliding today
Cannara Biotech Inc. saw its stock price slide by 2.67% today, closing at CA$1.82. Investors are left questioning the stock's future amidst a lack of recent news.
Why Cannara Biotech Inc. stock is rising today
Cannara Biotech Inc. has seen a 3.53% rise in its stock today, driven by strategic acquisitions and a solid market position in Québec's cannabis sector.
Why Cannara Biotech Inc. stock is gaining today
Cannara Biotech Inc. (LOVE.TO) is experiencing a positive shift in its stock price, reflecting investor confidence in its recent financial achievements and strategic initiatives.
Why Cannara Biotech Inc. stock is gaining today
Cannara Biotech Inc. stock has gained 1.22% today, closing at CA$1.66, buoyed by its record financial performance and strategic moves to enhance market access.
Why Cannara Biotech Inc. stock is tanking today
Cannara Biotech Inc. experienced a 1.20% decline in stock price today, closing at CA$1.64. This drop may reflect investor concerns about the company's future growth prospects despite recent acquisitions and financial achievements.
Why Cannara Biotech Inc. stock is sliding today
Cannara Biotech Inc. (LOVE.TO) closed down 2.41% at CA$1.62, reflecting investor concerns about the cannabis sector's volatility and the company's future performance.
